DV
Dividend Vision

CODX — Co-Diagnostics, Inc.

Co-Diagnostics, Inc. (CODX)

Total return is -99.2% over the past 9.1 years, 365.3 points behind SPY at 266.1%. Its deepest 1-year drawdown was 96.6%.

Co-Diagnostics, Inc. is a single-stock equity holding focused on molecular diagnostics and infectious disease testing. The fund does not currently pay distributions and carries no reported expense ratio or asset under management data. It appeals primarily to investors seeking exposure to the diagnostic testing sector rather than income-focused dividend investors.

CODX key facts

Asset type
Stock
Asset class
Equity
Inception date
07/12/2017
Distribution frequency
None
Last close
$1.40
Market cap
$5,491,118
Average volume
330417.0
Beta
2.88
Payout ratio
0.0
Forward P/E
15.361
EPS
$-32.26